CFEIY logo

China Feihe Limited (CFEIY) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

CFEIY representa a China Feihe Limited, una empresa del sector Consumer Defensive con un precio de $ (capitalización de mercado 0). La acción obtiene una puntuación de 50/100, una calificación moderada basada en 9 KPI cuantitativos.

Ultimo analisis: 17 mar 2026
Puntuación de IA de 50/100

China Feihe Limited (CFEIY) Descripción General del Negocio al Consumidor

CEOYoubin Leng
Empleados9590
Sede CentralBeijing, CN
Año de la oferta pública inicial (OPI)2020

China Feihe Limited is a leading infant milk formula producer in China, offering a range of nutritional products through a widespread distribution network encompassing both online platforms and traditional retail outlets, positioning it within the competitive packaged foods sector.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 17 mar 2026

Tesis de Inversión

China Feihe Limited presents a compelling investment case based on its established market position in the Chinese infant milk formula industry and its extensive distribution network. With a P/E ratio of 11.61 and a profit margin of 13.6%, the company demonstrates solid profitability. A dividend yield of 7.25% offers an attractive return to investors. Growth catalysts include expanding product lines and increasing penetration in lower-tier cities. However, investors may want to evaluate potential risks such as regulatory changes in the infant formula industry and competition from both domestic and international players. The company's beta of 0.56 suggests lower volatility compared to the overall market.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • Market capitalization of $4.52 billion, reflecting its significant presence in the Chinese infant milk formula market.
  • P/E ratio of 11.61, indicating a potentially undervalued stock relative to its earnings.
  • Profit margin of 13.6%, showcasing the company's ability to generate profits from its sales.
  • Gross margin of 63.4%, highlighting efficient cost management in production and sales.
  • Dividend yield of 7.25%, providing a substantial income stream for investors.

Competidores y Pares

Fortalezas

  • Strong brand recognition in China.
  • Extensive distribution network.
  • Diverse product portfolio.
  • Established research and development capabilities.

Debilidades

  • Heavy reliance on the Chinese market.
  • Vulnerability to regulatory changes in China.
  • Exposure to fluctuations in raw material costs.
  • Limited international presence.

Catalizadores

  • Ongoing: Expansion into new geographic markets within China, particularly lower-tier cities, is expected to drive revenue growth.
  • Ongoing: Product innovation and the introduction of premium infant milk formula products cater to evolving consumer preferences.
  • Ongoing: Continued growth in e-commerce sales through platforms like Tmall and JD.com.
  • Upcoming: Potential strategic partnerships or acquisitions to expand product portfolio and market reach.
  • Upcoming: Regulatory approvals for new product formulations or market expansions.

Riesgos

  • Ongoing: Intense competition from both domestic and international brands in the Chinese infant milk formula market.
  • Ongoing: Regulatory changes in China's infant milk formula industry could impact production and sales.
  • Potential: Fluctuations in raw material costs, such as milk powder and other ingredients, could affect profitability.
  • Potential: Food safety concerns and negative publicity could damage brand reputation and consumer trust.
  • Potential: Economic slowdown in China could reduce consumer spending on infant milk formula.

Oportunidades de crecimiento

  • Expansion into Lower-Tier Cities: China Feihe has the opportunity to further penetrate lower-tier cities in China, where demand for infant milk formula is growing rapidly. These markets often have less competition from international brands, allowing Feihe to gain market share. By leveraging its existing distribution network and tailoring products to local preferences, Feihe can tap into this significant growth potential. The market size for infant milk formula in lower-tier cities is estimated to be substantial, with ongoing growth expected through 2030.
  • Product Innovation and Premiumization: The company can drive growth by introducing new and innovative products, particularly in the premium segment. Chinese consumers are increasingly willing to pay more for high-quality and safe infant milk formula. Feihe can invest in research and development to create products with enhanced nutritional benefits and unique formulations. The premium infant milk formula market is projected to continue its expansion, offering significant revenue opportunities for Feihe.
  • E-commerce Channel Expansion: China Feihe can further expand its presence on e-commerce platforms such as Tmall, JD.com, and its own online channels. Online sales of infant milk formula are growing rapidly in China, driven by convenience and accessibility. By optimizing its online marketing strategies and improving its online customer service, Feihe can capture a larger share of the online market. This channel offers a direct-to-consumer approach, enhancing brand engagement and customer loyalty.
  • International Market Expansion: While primarily focused on the Chinese market, China Feihe has the potential to expand its presence in other international markets, particularly in Southeast Asia and other regions with significant Chinese diaspora populations. By adapting its products to local tastes and regulations, Feihe can tap into new sources of revenue and diversify its geographic risk. The global infant milk formula market is substantial, offering long-term growth opportunities for Feihe.
  • Strategic Partnerships and Acquisitions: China Feihe can pursue strategic partnerships and acquisitions to expand its product portfolio, enhance its distribution network, and gain access to new technologies. Collaborating with other companies in the food and beverage industry can provide synergies and accelerate growth. Acquisitions can also help Feihe to consolidate its market position and gain access to new markets or product categories. These strategic moves can strengthen Feihe's competitive advantage and drive long-term value creation.

Oportunidades

  • Expansion into lower-tier cities in China.
  • Product innovation and premiumization.
  • E-commerce channel expansion.
  • International market expansion.

Amenazas

  • Intense competition from domestic and international brands.
  • Changing consumer preferences.
  • Food safety concerns.
  • Economic slowdown in China.

Ventajas competitivas

  • Established brand reputation in the Chinese infant milk formula market.
  • Extensive distribution network across online and offline channels.
  • Strong research and development capabilities for product innovation.
  • Scale of operations providing cost advantages.

Acerca de CFEIY

Founded in 1962 and headquartered in Beijing, China Feihe Limited has grown to become a prominent player in the Chinese infant milk formula market. The company's core business revolves around the production and sale of infant milk formula products, catering primarily to the Mainland China market, with some presence in the United States. Over the years, China Feihe has expanded its product portfolio to include a variety of milk-based products, such as raw milk, adult milk powders, and liquid milk products. Additionally, the company offers health care products, soybean powder, goat milk powder, and nutritional supplements, including vitamins, minerals, and herbs. China Feihe distributes its products through an extensive network comprising distributors, e-commerce platforms like Tmall, JD.com, and Suning.com, its own website and mobile application (including WeChat), and approximately 2,000 offline customers with 110,000 retail points of sale as of December 31, 2021. This multi-channel approach allows the company to reach a broad customer base across different demographics and geographic locations within China.

Qué hacen

  • Produces and sells infant milk formula products.
  • Offers raw milk and adult milk powders.
  • Manufactures liquid milk products.
  • Provides health care products.
  • Produces soybean powder and goat milk powder.
  • Retails vitamins, minerals, herbs, and other nutritional supplements.

Modelo de Negocio

  • Manufactures and distributes infant milk formula and related products.
  • Sells products through distributors, e-commerce platforms, and its own website and mobile application.
  • Operates a distribution network of offline customers with numerous retail points of sale.

Contexto de la Industria

China Feihe operates within the competitive packaged foods industry, specifically focusing on the infant milk formula market in China. This market is characterized by increasing demand due to rising disposable incomes and urbanization. However, it is also subject to stringent regulations and intense competition from both domestic and international brands. The industry is experiencing a trend towards premiumization, with consumers increasingly seeking high-quality and safe products. China Feihe's established brand and distribution network position it to capitalize on these trends.

Clientes Clave

  • Infants and young children requiring milk formula.
  • Parents and caregivers seeking nutritional products for their children.
  • Adults consuming milk powders and health supplements.
Confianza de la IA: 80% Actualizado: 17 mar 2026

Finanzas

Gráfico e información

Precio de la acción de China Feihe Limited (CFEIY): Price data unavailable

Últimas noticias

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para CFEIY.

Objetivos de Precios

Análisis del precio objetivo de Wall Street para CFEIY.

MoonshotScore

50/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de CFEIY en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

Liderazgo: Youbin Leng

CEO

Youbin Leng is the CEO of China Feihe Limited, leading a workforce of 9,590 employees. His background includes extensive experience in the food and beverage industry, with a focus on dairy and nutritional products. He has held various leadership positions within China Feihe, contributing to the company's growth and expansion. His expertise spans across operations, marketing, and strategic planning.

Historial: Under Youbin Leng's leadership, China Feihe has strengthened its market position in the Chinese infant milk formula industry. He has overseen the expansion of the company's product portfolio and the enhancement of its distribution network. Key milestones include increased market share and improved financial performance. He has also focused on strengthening the company's brand reputation and ensuring product quality and safety.

Información de ADR de China Feihe Limited No patrocinado

An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company trading on U.S. stock exchanges. CFEIY is traded as a Level 1 ADR, meaning it trades over-the-counter (OTC) without needing to meet the stricter requirements of listed exchanges. This allows U.S. investors to invest in China Feihe more easily.

  • Ticker del mercado local: Hong Kong Stock Exchange (CFEI), China
  • Nivel de ADR: 1
  • Ratio de ADR: 1:1
  • Ticker del mercado local: CFEI
Riesgo cambiario: As an ADR, CFEIY is subject to currency risk. The value of the ADR is affected by fluctuations in the exchange rate between the U.S. dollar and the Chinese Yuan (CNY). If the CNY depreciates against the USD, the value of CFEIY in USD terms may decrease, impacting returns for U.S. investors.
Implicaciones fiscales: Dividends paid on CFEIY ADRs are subject to foreign dividend withholding tax in China. The standard withholding tax rate is typically around 10%. However, tax treaties between the U.S. and China may reduce this rate. U.S. investors may be able to claim a foreign tax credit on their U.S. tax return for the amount of foreign tax withheld.
Horario de negociación: The Hong Kong Stock Exchange (where CFEI trades) operates on a different time zone than U.S. markets. Its trading hours are typically 9:30 AM to 12:00 PM and 1:00 PM to 4:00 PM Hong Kong time (GMT+8). This translates to overnight and early morning trading hours in the U.S., potentially impacting the ability of U.S. investors to react to news and events in real-time.

Información del mercado OTC de CFEIY

The OTC Other tier represents the lowest tier of the over-the-counter (OTC) market. Companies in this tier often have limited financial disclosure, and may not meet minimum listing requirements of major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks carries higher risks due to the lack of regulatory oversight and potential for limited liquidity, requiring increased due diligence.

  • Nivel OTC: OTC Other
  • Estado de divulgación: Unknown
Liquidez: Liquidity for CFEIY on the OTC market is likely to be limited. This means lower trading volumes and wider bid-ask spreads, potentially making it difficult to buy or sell shares quickly and at desired prices. Investors may experience price volatility and should be prepared for potential delays in executing trades.
Factores de riesgo OTC:
  • Limited financial disclosure increases information asymmetry.
  • Lower trading volumes can lead to price volatility.
  • Wider bid-ask spreads increase transaction costs.
  • Potential for fraud or manipulation is higher on the OTC market.
  • Regulatory oversight is less stringent compared to listed exchanges.
Lista de verificación de diligencia debida:
  • Verify the company's registration and legal status.
  • Obtain and review the latest financial statements, if available.
  • Assess the company's management team and their track record.
  • Research the company's industry and competitive landscape.
  • Understand the risks associated with investing in OTC stocks.
  • Consult with a financial advisor before investing.
  • Check for any regulatory actions or legal proceedings against the company.
Señales de legitimidad:
  • Established operating history in the Chinese infant milk formula market.
  • Presence on major e-commerce platforms in China.
  • Significant market capitalization.
  • Dividend payments to shareholders.
  • Audited financial statements (if available).

Preguntas Comunes Sobre CFEIY

¿Cuáles son los factores clave para evaluar CFEIY?

China Feihe Limited (CFEIY) actualmente tiene una puntuación IA de 50/100, indicando puntuación moderada. Fortaleza clave: Strong brand recognition in China.. Riesgo principal a monitorear: Ongoing: Intense competition from both domestic and international brands in the Chinese infant milk formula market.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de CFEIY?

CFEIY actualmente puntúa 50/100 (Grado C) en el MoonshotScore, lo que sugiere calificación moderada. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de CFEIY?

Los precios de CFEIY se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre CFEIY?

La cobertura de analistas para CFEIY incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en CFEIY?

Las categorías de riesgo para CFEIY incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Ongoing: Intense competition from both domestic and international brands in the Chinese infant milk formula market.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de CFEIY?

La relación P/E para CFEIY compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.

¿Está CFEIY sobrevalorada o infravalorada?

Determinar si China Feihe Limited (CFEIY) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de CFEIY?

China Feihe Limited (CFEIY) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • Limited analyst coverage due to OTC listing.
  • Financial data may not be as readily available as for listed companies.
  • OTC stocks carry higher risks than exchange-listed stocks.
Fuentes de datos

Popular Stocks